(BMO) Bank of Montreal - Overview
Exchange: NYSE •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA0636711016
Stock: Banking, Wealth Management, Investments, Capital Markets
Total Rating 41
Risk 28
Buy Signal 0.12
| Risk 5d forecast | |
|---|---|
| Volatility | 22.4% |
| Relative Tail Risk | -5.99% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.97 |
| Alpha | 35.14 |
| Character TTM | |
|---|---|
| Beta | 0.761 |
| Beta Downside | 0.863 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.00% |
| CAGR/Max DD | 1.21 |
EPS (Earnings per Share)
Revenue
Description: BMO Bank of Montreal March 05, 2026
Bank of Montreal (BMO) is a diversified financial services institution operating primarily in North America. Its business model encompasses personal and commercial banking, wealth management, and capital markets.
The companys personal and commercial banking services, offered in both Canada and the U.S., include deposits, lending, and advisory services. Wealth management, a high-margin sector, provides investing, banking, and advisory solutions for various client segments, including institutional and high-net-worth individuals. Capital Markets offers a broad range of services such as debt and equity capital raising, mergers and acquisitions advice, and sales and trading solutions across various asset classes.
Considering the breadth of BMOs operations, further investigation into its segment-specific performance metrics could provide valuable insights. For detailed financial data and analytical tools, consider exploring platforms like ValueRay.
Headlines to watch out for
Canadian P&C loan growth drives revenue | US P&C deposit costs impact profitability | Capital Markets trading volumes affect earnings | Interest rate changes influence net interest margin
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 9.06b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.20 > 1.0 |
| NWC/Revenue: -850.9% < 20% (prev -1094 %; Δ 242.8% < -1%) |
| CFO/TA 0.01 > 3% & CFO 12.70b > Net Income 9.06b |
| Net Debt (61.73b) to EBITDA (13.90b): 4.44 < 3 |
| Current Ratio: 0.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (710.2m) vs 12m ago -2.52% < -2% |
| Gross Margin: 43.25% > 18% (prev 0.37%; Δ 4288 % > 0.5%) |
| Asset Turnover: 5.26% > 50% (prev 5.46%; Δ -0.20% > 0%) |
| Interest Coverage Ratio: 0.30 > 6 (EBITDA TTM 13.90b / Interest Expense TTM 40.36b) |
Altman Z'' -2.73
| A: -0.45 (Total Current Assets 418.25b - Total Current Liabilities 1073.68b) / Total Assets 1458.13b |
| B: 0.03 (Retained Earnings 47.72b / Total Assets 1458.13b) |
| C: 0.01 (EBIT TTM 12.01b / Avg Total Assets 1463.11b) |
| D: 0.06 (Book Value of Equity 77.62b / Total Liabilities 1372.38b) |
| Altman-Z'' Score: -2.73 = D |
Beneish M -3.15
| DSRI: 1.17 (Receivables 45.20b/40.16b, Revenue 77.03b/80.22b) |
| GMI: 0.85 (GM 43.25% / 36.73%) |
| AQI: 0.84 (AQ_t 0.71 / AQ_t-1 0.85) |
| SGI: 0.96 (Revenue 77.03b / 80.22b) |
| TATA: -0.00 (NI 9.06b - CFO 12.70b) / TA 1458.13b) |
| Beneish M-Score: -3.15 (Cap -4..+1) = AA |
What is the price of BMO shares?
As of March 08, 2026, the stock is trading at USD 142.12 with a total of 1,069,778 shares traded.
Over the past week, the price has changed by -1.26%, over one month by +0.28%, over three months by +13.24% and over the past year by +50.75%.
Over the past week, the price has changed by -1.26%, over one month by +0.28%, over three months by +13.24% and over the past year by +50.75%.
Is BMO a buy, sell or hold?
Bank of Montreal has received a consensus analysts rating of 3.53.
Therefor, it is recommend to hold BMO.
- StrongBuy: 2
- Buy: 5
- Hold: 7
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the BMO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 141 | -0.8% |
| Analysts Target Price | 141 | -0.8% |
BMO Fundamental Data Overview March 06, 2026
Market Cap CAD = 140.89b (103.13b USD * 1.3662 USD.CAD)
P/E Trailing = 16.6511
P/E Forward = 13.8889
P/S = 3.0802
P/B = 1.6496
P/EG = 1.4564
Revenue TTM = 77.03b CAD
EBIT TTM = 12.01b CAD
EBITDA TTM = 13.90b CAD
Long Term Debt = 169.36b CAD (from longTermDebt, last quarter)
Short Term Debt = 135.57b CAD (from shortTermDebt, last quarter)
Debt = 168.46b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 61.73b CAD (from netDebt column, last quarter)
Enterprise Value = -63.70b CAD (140.89b + Debt 168.46b - CCE 373.05b)
Interest Coverage Ratio = 0.30 (Ebit TTM 12.01b / Interest Expense TTM 40.36b)
EV/FCF = -5.80x (Enterprise Value -63.70b / FCF TTM 10.97b)
FCF Yield = -17.23% (FCF TTM 10.97b / Enterprise Value -63.70b)
FCF Margin = 14.25% (FCF TTM 10.97b / Revenue TTM 77.03b)
Net Margin = 11.77% (Net Income TTM 9.06b / Revenue TTM 77.03b)
Gross Margin = 43.25% ((Revenue TTM 77.03b - Cost of Revenue TTM 43.71b) / Revenue TTM)
Gross Margin QoQ = 46.78% (prev 44.10%)
Tobins Q-Ratio = -0.04 (set to none) (Enterprise Value -63.70b / Total Assets 1458.13b)
Interest Expense / Debt = 5.66% (Interest Expense 9.53b / Debt 168.46b)
Taxrate = 25.14% (836.0m / 3.33b)
NOPAT = 8.99b (EBIT 12.01b * (1 - 25.14%))
Current Ratio = 0.39 (Total Current Assets 418.25b / Total Current Liabilities 1073.68b)
Debt / Equity = 1.97 (Debt 168.46b / totalStockholderEquity, last quarter 85.70b)
Debt / EBITDA = 4.44 (Net Debt 61.73b / EBITDA 13.90b)
Debt / FCF = 5.62 (Net Debt 61.73b / FCF TTM 10.97b)
Total Stockholder Equity = 86.57b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.62% (Net Income 9.06b / Total Assets 1458.13b)
RoE = 10.47% (Net Income TTM 9.06b / Total Stockholder Equity 86.57b)
RoCE = 4.69% (EBIT 12.01b / Capital Employed (Equity 86.57b + L.T.Debt 169.36b))
RoIC = 2.51% (NOPAT 8.99b / Invested Capital 358.63b)
WACC = 6.28% (E(140.89b)/V(309.35b) * Re(8.72%) + D(168.46b)/V(309.35b) * Rd(5.66%) * (1-Tc(0.25)))
Discount Rate = 8.72% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.27%
[DCF] Terminal Value 78.76% ; FCFF base≈12.20b ; Y1≈8.01b ; Y5≈3.65b
[DCF] Fair Price = 60.13 (EV 104.20b - Net Debt 61.73b = Equity 42.46b / Shares 706.2m; r=6.28% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -7.86 | EPS CAGR: 2.01% | SUE: 0.46 | # QB: 0
Revenue Correlation: 77.51 | Revenue CAGR: 29.51% | SUE: 0.66 | # QB: 0
EPS next Quarter (2026-04-30): EPS=3.43 | Chg7d=+0.080 | Chg30d=+0.144 | Revisions Net=+9 | Analysts=13
EPS current Year (2026-10-31): EPS=14.22 | Chg7d=+0.421 | Chg30d=+0.555 | Revisions Net=+14 | Growth EPS=+17.0% | Growth Revenue=+6.6%
EPS next Year (2027-10-31): EPS=16.11 | Chg7d=+0.265 | Chg30d=+0.546 | Revisions Net=+13 | Growth EPS=+13.3% | Growth Revenue=+4.4%
[Analyst] Revisions Ratio: +0.82 (10 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.7% (Discount Rate 8.7% - Earnings Yield 6.0%)
[Growth] Growth Spread = +6.1% (Analyst 8.8% - Implied 2.7%)
P/E Trailing = 16.6511
P/E Forward = 13.8889
P/S = 3.0802
P/B = 1.6496
P/EG = 1.4564
Revenue TTM = 77.03b CAD
EBIT TTM = 12.01b CAD
EBITDA TTM = 13.90b CAD
Long Term Debt = 169.36b CAD (from longTermDebt, last quarter)
Short Term Debt = 135.57b CAD (from shortTermDebt, last quarter)
Debt = 168.46b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 61.73b CAD (from netDebt column, last quarter)
Enterprise Value = -63.70b CAD (140.89b + Debt 168.46b - CCE 373.05b)
Interest Coverage Ratio = 0.30 (Ebit TTM 12.01b / Interest Expense TTM 40.36b)
EV/FCF = -5.80x (Enterprise Value -63.70b / FCF TTM 10.97b)
FCF Yield = -17.23% (FCF TTM 10.97b / Enterprise Value -63.70b)
FCF Margin = 14.25% (FCF TTM 10.97b / Revenue TTM 77.03b)
Net Margin = 11.77% (Net Income TTM 9.06b / Revenue TTM 77.03b)
Gross Margin = 43.25% ((Revenue TTM 77.03b - Cost of Revenue TTM 43.71b) / Revenue TTM)
Gross Margin QoQ = 46.78% (prev 44.10%)
Tobins Q-Ratio = -0.04 (set to none) (Enterprise Value -63.70b / Total Assets 1458.13b)
Interest Expense / Debt = 5.66% (Interest Expense 9.53b / Debt 168.46b)
Taxrate = 25.14% (836.0m / 3.33b)
NOPAT = 8.99b (EBIT 12.01b * (1 - 25.14%))
Current Ratio = 0.39 (Total Current Assets 418.25b / Total Current Liabilities 1073.68b)
Debt / Equity = 1.97 (Debt 168.46b / totalStockholderEquity, last quarter 85.70b)
Debt / EBITDA = 4.44 (Net Debt 61.73b / EBITDA 13.90b)
Debt / FCF = 5.62 (Net Debt 61.73b / FCF TTM 10.97b)
Total Stockholder Equity = 86.57b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.62% (Net Income 9.06b / Total Assets 1458.13b)
RoE = 10.47% (Net Income TTM 9.06b / Total Stockholder Equity 86.57b)
RoCE = 4.69% (EBIT 12.01b / Capital Employed (Equity 86.57b + L.T.Debt 169.36b))
RoIC = 2.51% (NOPAT 8.99b / Invested Capital 358.63b)
WACC = 6.28% (E(140.89b)/V(309.35b) * Re(8.72%) + D(168.46b)/V(309.35b) * Rd(5.66%) * (1-Tc(0.25)))
Discount Rate = 8.72% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.27%
[DCF] Terminal Value 78.76% ; FCFF base≈12.20b ; Y1≈8.01b ; Y5≈3.65b
[DCF] Fair Price = 60.13 (EV 104.20b - Net Debt 61.73b = Equity 42.46b / Shares 706.2m; r=6.28% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -7.86 | EPS CAGR: 2.01% | SUE: 0.46 | # QB: 0
Revenue Correlation: 77.51 | Revenue CAGR: 29.51% | SUE: 0.66 | # QB: 0
EPS next Quarter (2026-04-30): EPS=3.43 | Chg7d=+0.080 | Chg30d=+0.144 | Revisions Net=+9 | Analysts=13
EPS current Year (2026-10-31): EPS=14.22 | Chg7d=+0.421 | Chg30d=+0.555 | Revisions Net=+14 | Growth EPS=+17.0% | Growth Revenue=+6.6%
EPS next Year (2027-10-31): EPS=16.11 | Chg7d=+0.265 | Chg30d=+0.546 | Revisions Net=+13 | Growth EPS=+13.3% | Growth Revenue=+4.4%
[Analyst] Revisions Ratio: +0.82 (10 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.7% (Discount Rate 8.7% - Earnings Yield 6.0%)
[Growth] Growth Spread = +6.1% (Analyst 8.8% - Implied 2.7%)